Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-192-6 | CAS number: 104-29-0
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Results of available in vitro studies:
- AMES test: negative
- mammalian cell gene mutation test (HPRT-locus): negative.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
No study available.
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The genetic toxicity of Chlorphenesin was investigated with different types of in vitro tests.
- AMES test: the test item Chlorphenesin was examined in 2017 for the ability to induce gene mutations in tester strains of Salmonella typhimurium and Escherichia coli, as measured by reversion of auxotrophic strains to prototrophy till concentration 5000 μg/plate. The test was negative for all 5 strains (TA1535, TA1537, TA98, TA100 and WP2 uvrA) with and without metabolic activation. Similar results were obtained in other AMES tests performed before 2017.
- Structural and numerical chromosome aberrations: a negative chromosomal aberration test with human lymphocytes exposed in vitro to Chlorphenesin is reported in literature.
- HPRT: Chlorphensin was tested in 1987 for its ability to induce forward mutation at the functionally hemizygous hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus in Chinese hamster ovary (CHO) cells in vitro both in the presence and the absence of exogenous metabolic activation in the form of Aroclor 1254-induced rat liver S-9. Treatment of CHO cells with Chlorphensin up to its limit of toxicity (1500 µg/ml) induced dose-related cytotoxicity in all tests in the presence and absence of S-9 mix. Chlorphensin failed to induce a significant dose-related increase in mutant frequency in all tests in the presence and absence of S-9.
Justification for classification or non-classification
Chlorphenesin is not classified for genetic toxicity according to the CLP Regulation (EC.n.1272/2008). For justificationsee the results of available studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
